Jackson, Sarah E.
Brown, Jamie
Shahab, Lion
Cox, Sharon
Funding for this research was provided by:
Cancer Research UK (PRCRPG-Nov21\100002, PRCRPG-Nov21\100002, PRCRPG-Nov21\100002, PRCRPG-Nov21\100002)
Article History
Received: 14 June 2024
Accepted: 25 October 2024
First Online: 31 October 2024
Declarations
:
: Ethical approval for the STS was granted originally by the UCL Ethics Committee (ID 0498/001). The data are not collected by UCL and are anonymized when received by UCL. All participants provided verbal consent which was recorded on computers by trained interviewers.
: Not applicable.
: JB has received unrestricted research funding from Pfizer and J&J, who manufacture smoking cessation medications. LS has received honoraria for talks, unrestricted research grants and travel expenses to attend meetings and workshops from manufactures of smoking cessation medications (Pfizer; J&J), and has acted as paid reviewer for grant awarding bodies and as a paid consultant for health care companies. All authors declare no financial links with tobacco companies, e-cigarette manufacturers, or their representatives.